Concepedia

Ángel Guerrero Zotano

ÁG

3

Publications

643

Citations

3

H-Index

2014

Active since

Affiliations

Fundación Instituto Valenciano de Oncología(Current)

Curtin University

Institut Gustave Roussy

University Hospital Centre Zagreb

Rigshospitalet

Ángel Guerrero Zotano is an author at Fundación Instituto Valenciano de Oncología specializing in oncology, clinical trials, and pharmacotherapy.

Top concepts

Publications per year

2014–2023

3

Publications

3

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Arlene Chan, Suzette Delaloge, Frankie A. Holmes et al. · The Lancet Oncology · 2016 · 551 citations

, , +9

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

Eduardo Martínez de Dueñas, Ana Lluch Hernández, Ángel Guerrero Zotano et al. · Breast Cancer Research and Treatment · 2014 · 65 citations · Full text

Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial

Frankie A. Holmes, Beverly Moy, Suzette Delaloge et al. · European Journal of Cancer · 2023 · 27 citations · Full text

Rows per page

1–3 of 3